Publications by authors named "Ivan Ferkolj"

Claim this Profile
E
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease.
Jurij Hanžel, Nejc Sever, Ivan Ferkolj, Borut Štabuc, Nataša Smrekar

United European Gastroenterol J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease.
David Drobne, Tina Kurent, Saša Golob, Polona Švegl, Polona Rajar, Ivan Ferkolj

Aliment Pharmacol Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease.
Natasa Smrekar, David Drobne, Lojze M Smid, Ivan Ferkolj, Borut Stabuc

Radiol Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success and safety of high infliximab trough levels in inflammatory bowel disease.
David Drobne, Tina Kurent, Sasa Golob, Polona Svegl, Polona Rajar, Ivan Ferkolj

Scand J Gastroenterol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease.
Cvetka Pernat Drobež, Katja Repnik, Mario Gorenjak, Ivan Ferkolj, Rinse K Weersma

Eur J Gastroenterol Hepatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype.
Cvetka Pernat Drobež, Ivan Ferkolj, Uroš Potočnik, Katja Repnik

Genet Test Mol Biomarkers· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scurvy - surprisingly not yet extinct.
Žiga Rotar, Ivan Ferkolj, Matija Tomšič, Alojzija Hočevar

Vasc Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin Level Before Treatment and Genetic Polymorphism in HFE Gene as Predictive Markers for Response to Adalimumab in Crohn's Disease Patients.
Katja Repnik, Silvo Koder, Pavel Skok, Ivan Ferkolj, Uroš Potočnik

Biochem Genet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Pharmacogenomic Study of Crohn's Disease Patients during Routine Therapy with Anti-TNF-α Drug Adalimumab: Contribution of ATG5, NFKB1, and CRP Genes to Pharmacodynamic Variability.
Matjaž Deželak, Katja Repnik, Silvo Koder, Ivan Ferkolj, Uroš Potočnik

OMICS· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphism in ATG16L1 gene influences the response to adalimumab in Crohn's disease patients.
Silvo Koder, Katja Repnik, Ivan Ferkolj, Cvetka Pernat, Pavel Skok

Pharmacogenomics· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing cytomegalovirus in patients with inflammatory bowel disease--by immunohistochemistry or polymerase chain reaction?
Nina Zidar, Ivan Ferkolj, Katja Tepeš, Borut Štabuc, Nika Kojc

Virchows Arch· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal hemorrhage due to thrombosis and rupture of the portal vein and hepatic artery.
Ivan Ferkolj, Jadranka Vrh-Jermancic, Borut Stabuc

Wien Klin Wochenschr· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute biliary pancreatitis: detection of common bile duct stones with endoscopic ultrasound.
Borut Stabuc, David Drobne, Ivan Ferkolj, Andrej Gruden, Janez Jereb

Eur J Gastroenterol Hepatol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of clinical response to anti-TNF treatment by oral parameters in Crohn's disease.
Dusan Groselj, Igor Grabec, Katja Seme, Alojz Ihan, Ivan Ferkolj

Hepatogastroenterology· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
Ivan Ferkolj, Alojzija Hocevar, Rastko Golouh, Mateja Dolenc Voljc

Acta Dermatovenerol Alp Pannonica Adriat· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease.
Ivan Ferkolj, Alojz Ihan, Sasa Markovic, Zeljka Veceric, Maja Pohar

J Gastrointestin Liver Dis· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease.
Ivan Ferkolj, Alojz Ihan, Sasa Markovic

Hepatogastroenterology· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis